诺和诺德司美格鲁肽:最高周剂量提至7.2毫克

和讯网
Jan 16

【1月16日,英国药管局批准诺和诺德司美格鲁肽最高周剂量提至7.2毫克】1月16日,英国药品和保健品管理局发布声明,批准诺和诺德司美格鲁肽最高周使用剂量提升至7.2毫克。该监管机构称,此剂量方案要通过三次2.4毫克注射达成,仅用于成年肥胖症患者体重管理,且要配合低热量饮食与运动。该机构还补充,此方案不适用于体重指数低于30kg/m?、用Wegovy管理体重的超重患者,也不适用于用Wegovy降低...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10